| Literature DB >> 32751487 |
Boya Nugraha1, Amin Riat1, Samaneh Khoshandam Ghashang1, Luqman Eljurnazi1, Christoph Gutenbrunner1.
Abstract
Fasting during a long period (17-18 h/day) may affect daily performance. Fatigue is one of important parameters to observe for this effect. This study aimed to determine the effect of Ramadan fasting (RF)-particularly on fatigue in both young males and females. Sleepiness, mood-related symptoms (MRSs) and body composition (BC) were determined, too. Thirty-four young males and females were recruited and performed RF. They were assessed for fatigue, sleepiness, MRS and BC at T1 (one week before RF), T2 (mid of RF), T3 (last days of RF), T4 (one week after RF) and T5 (one month after RF). The assessments were done in the morning, except for fatigue and sleepiness, which were also assessed in the afternoon and evening of T1 to T5. This study observed numerous positive effects to RF. After they began fasting and compared to T1, participants experienced (1) significantly less fatigue; (2) small to large improvement of MRSs; and (3) positive changes relating to BC. RF did not appear to have a significant effect on participants' sleepiness scores. Ultimately, this study illustrates how prolonged fasting, like RF, benefits the youth, particularly by decreasing fatigue, improving MRSs and positively impacting BC.Entities:
Keywords: Ramadan; body composition; fasting; fatigue; health; mood
Mesh:
Year: 2020 PMID: 32751487 PMCID: PMC7469051 DOI: 10.3390/nu12082281
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Study design of RF.
| Time Point of Assessment and Assessment Parameters | |||||
|---|---|---|---|---|---|
| T1 | T2 | T3 | T4 | T5 | |
|
| BC, FSS, ESS, HADS, BDI-II | BC, FSS, ESS, HADS, BDI-II | BC, FSS, ESS, HADS, BDI-II | BC, FSS, ESS, HADS, BDI-II | BC, FSS, ESS, HADS, BDI-II |
|
| FSS, ESS | FSS, ESS | FSS, ESS | FSS, ESS | FSS, ESS |
|
| FSS, ESS | FSS, ESS | FSS, ESS | FSS, ESS | FSS, ESS |
Note: RF—Ramadan fasting; BC—body composition; FSS—fatigue severity scale; ESS—Epworth sleepiness scales; HADS—hospital anxiety depression scale; BDI-II—Beck’s depression inventory-II.
Figure 1Flow chart recruitment of participants.
Baseline clinical characteristics of participants.
| All Participants | Male | Female | ||
|---|---|---|---|---|
| Age | 25.1 ± 0.8 | 24.8 ± 1.0 | 25.5 ± 1.2 | 0.65 |
| Caucasian/Other | 23/11 | 14/5 | 9/6 | 0.48 |
|
| ||||
| BW (kg) | 72.0 ± 2.3 | 77.31 ± 3.1 | 65.3 ± 2.3 | <0.01 |
| BMI (kg/m2) | 24.8 ± 0.6 | 25.10 ± 0.9 | 24.4 ± 0.8 | 0.56 |
| SMM (kg) | 30.0 ± 1.2 | 34.60 ± 1.2 | 24.2 ± 0.8 | <0.001 |
| BFM (kg) | 18.4 ± 1.2 | 16.2 ± 1.7 | 21.1 ± 1.5 | <0.05 |
| FFM (kg) | 53.6 ± 1.9 | 61.1 ± 2.0 | 44.2 ± 1.4 | <0.001 |
| BFP (%) | 25.4 ± 1.5 | 20.2 ± 1.5 | 31.9 ± 1.6 | <0.001 |
| BWM (kg) | 39.3 ± 1.4 | 44.8 ± 1.4 | 32.4 ± 1.0 | <0.001 |
| BMR (J/(h kg)) | 1528.5 ± 41.4 | 1686.0 ± 85.3 | 1324.7 ± 30.3 | <0.001 |
|
| ||||
| Anxiety (HADS-A) | 6.2 ± 0.6 | 6.6 ± 0.6 | 5.9 ± 1.1 | 0.57 |
| Depression (HADS-D) | 4.4 ± 0.6 | 4.8 ± 0.7 | 4.0 ± 0.8 | 0.49 |
| Depression (BDI-II) | 10.9 ± 1.3 | 9.5 ± 1.3 | 12.7 ± 2.3 | 0.21 |
| Fatigue severity scale (Median (IQR)) | 3.1 (2.1–4.5) | 3.0 (2.4–4.4) | 3.3 (2.1–4.8) | 0.73 |
| Epworth sleepiness scale (Median (IQR)) | 7.0 (5.0–10.0) | 7.0 (5.0–10.0) | 7.4 (5.0–10.0) | 0.89 |
Baseline data of age, race, BC parameters, mood, fatigue and sleepiness of all participants, only males and females. p-values were tested by using t-test or Mann–Whitney-U test (FSS and ESS).
Figure 2Patterns of fatigue (A) and sleepiness (B) scores during RF at T1 (one week before RF; n = 34), T2 (mid of RF; n = 34), T3 (last days of RF; n = 34), T4 (one week after RF; n = 34) and T5 (one month after RF; n = 34). Both fatigue and sleepiness were assessed in the morning, afternoon and evening. Data presented as median.
Fatigue and sleepiness scores during RF (all participants).
| Time Point |
| ||||||
|---|---|---|---|---|---|---|---|
| T1 ( | T2 ( | T3 ( | T4 ( | T5 ( | |||
|
| |||||||
| Morning | 3.1 (2.1–4.5) | 2.6 (2.2–3.9) | 2.67 (1.4–3.9) | 2.1 (1.2–3.9) | 3.0 (1.2–4.2) | <0.05 | <0.001 § |
| Afternoon | 3.2 (1.9–4.4) | 2.6 (1.8–3.7) | 3.15 (1.6–4.7) | 2.4 (1.2–3.8) | 2.1 (1.2–4.0) | 0.16 | |
| Evening | 3.4 (2.1–4.6) | 2.7 (1.7–4.4) | 3.28 (1.5–4.6) | 2.5 (1.3–4.1) | 2.2 (1.2–3.6) | <0.01 | |
|
| |||||||
| Morning | 7.0 (5.0–10.0) | 7.0 (3.75–10.00) | 6.0 (2.0–9.0) | 6.0 (1.8–9.2) | 6.8 (2.0–10.2) | 0.37 | 0.66 § |
| Afternoon | 7.5 (2.8–10.0) | 6.00 (1.8–9.2) | 7.50 (3.0–11.2) | 8.0 (2.0–11.0) | 6.8 (2.0–10.2) | 0.44 | |
| Evening | 9.0 (5.0–11.0) | 7.0 (3.8–10.0) | 9.00 (3.0–13.2) | 8.5 (4.5–11.2) | 7.3 (3.8–11.2) | 0.87 | |
Note: § Friedman-rank test followed by post hoc-test with Bonferroni correction.
Figure 3(A,D) Patterns of fatigue and sleepiness during RF in male and female in the morning; (B,E) afternoon and (C,F) and evening; (d,e) significant difference between male and female at T4 and T5, respectively. n at each time point for male = 19, female = 15. Data presented as median. * p < 0.05; ** p < 0.01.
ES of fatigue and sleepiness scores during RF in the morning, afternoon and evening between T1 and T3.
| ES | ||||
|---|---|---|---|---|
| All Participants | Male | Female | ||
| FSS | Morning | 0.07 | 0.08 | 0.08 |
| Afternoon | 0.01 | 0.03 | 0.26 | |
| Evening | 0.04 | 0.00 | 0.23 | |
| ESS | Morning | 0.07 | 0.08 | 0.01 |
| Afternoon | 0.02 | 0.00 | 0.10 | |
| Evening | 0.00 | 0.00 | 0.05 | |
Note: ES—effect size; FSS—fatigue severity scale; ESS—Epworth sleepiness scale.
Figure 4Patterns of MRSs during RF. (A–C) All participants; (D–F) subgroup male and female. Data presented in mean and SEM. * p < 0.05; ** p < 0.01.
Cohen’s ES of MRSs between T1 and T3.
| ES Cohen’s (d) | |||
|---|---|---|---|
| All Participants | Male | Female | |
| HADS-A | 0.54 | 0.80 | 0.31 |
| HADS-D | 0.29 | 0.18 | 0.43 |
| BDI-II | 0.54 | 0.58 | 0.54 |
Note: ES: effect size; HADS-A/D—hospital and anxiety depression scale-anxiety/depression; BDI-II—Beck’s depression inventory.
Figure 5The alteration of BC parameters during RF in all participants (A: body weight; B: body mass index; C: body fat mass; D: body fat percentage; E: skeletal muscle mass; F: fat free mass; G: body water mass; H: basal metabolic rate). Data presented in mean and SEM. * p < 0.05; ** p < 0.01; *** p < 0.001.
Cohen’s ES (d) of BC parameters of all participants between T1 and T3.
| ES Cohen’s (d) | |
|---|---|
| BW | 0.08 |
| BMI | 0.14 |
| SMM | 0.11 |
| BFM | 0.02 |
| FFM | 0.10 |
| BFP | 0.07 |
| BWM | 0.10 |
| BMR | 0.10 |
Note: ES—effect size; BMI—body mass index; BFP—body fat percentage; BW—body weight; BWM—body water mass; SMM—skeletal muscle mass; BFM—body fat mass; FFM—fat-free mass; BMR—basal metabolic rate.
Figure 6Alteration of BC during RF in subgroup male (n = 19) of and female (n = 15). (a–e) significant difference between male and female at T1, T2, T3, T4 and T5, respectively. (A: Body weight; B: Body mass index; C: Body fat mass; D: Body fat percentage; E: Skeletal muscle mass; F: Fat free mass; G: Body water mass; H: Basal metabolic rate). Data presented in mean and SEM. * p < 0.05; ** p < 0.01.
Cohen’s (d) ES of BC parameters between T1 and T3.
| ES Cohen’s d | ||
|---|---|---|
| Male | Female | |
| BW | 0.06 | 0.14 |
| BMI | 0.13 | 0.16 |
| SMM | 0.12 | 0.30 |
| BFM | 0.00 | 0.04 |
| FFM | 0.10 | 0.27 |
| BFP | 0.05 | 0.15 |
| BWM | 0.10 | 0.27 |
| BMR | 0.10 | 0.27 |
Note: ES—effect size; BMI—body mass index; BFP—body fat percentage; BW—body weight; BWM—body water mass; SMM—skeletal muscle mass; BFM—body fat mass; FFM—fat-free mass; BMR—basal metabolic rate.